Murphy USA director awarded and settles RSUs

Murphy USA Inc. director Rosemary Turner reported equity compensation activity involving restricted stock units (RSUs).

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Murphy USA Inc. director Rosemary Turner reported equity compensation activity involving restricted stock units (RSUs). On 02/12/2026 she acquired 421 RSUs under the 2023 Omnibus Incentive Plan, including dividend equivalent units, at an exercise price of $0 per unit.

On 02/13/2026, 349 RSUs (including related dividend equivalents) vested and were settled on a one-for-one basis into 349 shares of Murphy USA common stock at $0 per share through a derivative conversion. After these transactions, she directly held 349 common shares and 1,484.892 RSUs.

Insider Trade Summary

349 shares exercised/converted

Exercise 3 txns

Insider Turner Rosemary

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	349	$0.00	$0.00
Exercise	Common Stock	349	$0.00	$0.00
Grant/Award	Restricted Stock Unit	421	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 1,484.892 contracts (Direct); Common Stock — 349 shares (Direct)

Footnotes (4)

F1. Represents Restricted Stock Units ("RSUs") and corresponding dividend equivalents accrued thereon granted to the Reporting Person that have vested and settled in shares of the Company's stock on a one-for-one basis, except for fractional dividend equivalents which have been settled in cash.
F2. Award granted under the 2023 Omnibus Incentive Plan.
F3. These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.
F4. Includes dividend equivalent units accrued with respect to the underlying RSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Murphy USA (MUSA) director Rosemary Turner report?

Murphy USA director Rosemary Turner reported RSU-related equity compensation transactions, not open-market trades. She received 421 restricted stock units (RSUs) on 02/12/2026, then 349 RSUs vested and converted into 349 shares of common stock on 02/13/2026, all at $0 per unit.

How many Murphy USA (MUSA) shares did Rosemary Turner receive from RSU vesting?

Rosemary Turner received 349 Murphy USA common shares from RSU vesting. On 02/13/2026, 349 RSUs, including dividend equivalents, settled into 349 shares at $0 per share via a derivative conversion, moving them from RSUs into directly held stock.

What new restricted stock units did Rosemary Turner receive from Murphy USA (MUSA)?

Rosemary Turner was granted 421 restricted stock units (RSUs) on 02/12/2026. The award, including dividend equivalent units, was issued under Murphy USA’s 2023 Omnibus Incentive Plan at an exercise price of $0, increasing her outstanding RSU balance to 1,833.892 units immediately after the grant.

How many restricted stock units does Rosemary Turner hold after these Murphy USA (MUSA) transactions?

After the reported transactions, Rosemary Turner holds 1,484.892 restricted stock units. She first reached 1,833.892 RSUs following the 421-unit grant on 02/12/2026, then 349 RSUs vested and converted into common shares on 02/13/2026, leaving 1,484.892 RSUs outstanding.

Were Rosemary Turner’s Murphy USA (MUSA) transactions open-market buys or sales?

The reported activity reflects equity awards and a derivative conversion, not open-market buying or selling. RSUs were granted at $0 under the 2023 Omnibus Incentive Plan, then 349 RSUs vested and converted into common shares at $0 per share for compensation purposes.

Under what plan were Rosemary Turner’s Murphy USA (MUSA) RSUs granted?

Rosemary Turner’s restricted stock units were granted under Murphy USA’s 2023 Omnibus Incentive Plan. The filing notes that the RSU awards, including dividend equivalent units, come from this plan and generally do not carry a conversion price, exercisable date, or expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/17/2026 - 04:49 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turner Rosemary

(Last)

(First)

(Middle)

200 E. PEACH STREET

(Street)

EL DORADO

71730

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Murphy USA Inc. [ MUSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/13/2026		M		349⁽¹⁾	A	$0	349	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit⁽²⁾	⁽³⁾	02/12/2026		A		421		⁽³⁾	⁽³⁾	Common Stock	421	$0	1,833.892⁽⁴⁾	D
Restricted Stock Unit⁽²⁾	⁽³⁾	02/13/2026		M			349⁽¹⁾	⁽³⁾	⁽³⁾	Common Stock	349	$0	1,484.892⁽⁴⁾	D

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") and corresponding dividend equivalents accrued thereon granted to the Reporting Person that have vested and settled in shares of the Company's stock on a one-for-one basis, except for fractional dividend equivalents which have been settled in cash.

2. Award granted under the 2023 Omnibus Incentive Plan.

3. These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.

4. Includes dividend equivalent units accrued with respect to the underlying RSUs.

	/s/ Gregory L. Smith, attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR